Cetera Advisor Networks LLC Tandem Diabetes Care Inc Transaction History

Cetera Advisor Networks LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$35.86 - $46.5 $35,860 - $46,500	-1,000 Reduced 9.95%	9,050 $367,000
Q4 2022 Feb 14, 2023	SELL	$35.49 - $56.15 $97,810 - $154,749	-2,756 Reduced 21.52%	10,050 $451,000
Q3 2022 Nov 10, 2022	SELL	$43.76 - $68.97 $42,228 - $66,556	-965 Reduced 7.01%	12,806 $613,000
Q2 2022 Aug 11, 2022	BUY	$53.22 - $123.09 $18,786 - $43,450	353 Added 2.63%	13,771 $815,000
Q1 2022 May 12, 2022	SELL	$101.89 - $150.09 $69,794 - $102,811	-685 Reduced 4.86%	13,418 $1.56 Million
Q4 2021 Feb 14, 2022	SELL	$118.18 - $153.21 $21,626 - $28,037	-183 Reduced 1.28%	14,103 $2.12 Million
Q3 2021 Nov 16, 2021	BUY	$93.51 - $129.4 $295,959 - $409,551	3,165 Added 28.46%	14,286 $1.71 Million
Q2 2021 Aug 13, 2021	BUY	$77.0 - $100.19 $856,317 - $1.11 Million	11,121 New	11,121 $1.08 Million
Q3 2020 Nov 13, 2020	SELL	$95.43 - $116.09 $146,198 - $177,849	-1,532 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$60.05 - $98.92 $91,996 - $151,545	1,532 New	1,532 $152,000
Q2 2018 Aug 14, 2018	SELL	$4.9 - $23.64 $115,150 - $555,540	-23,500 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$2.35 - $4.96 $55,225 - $116,560	23,500 New	23,500 $117,000

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.94B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.